Skip to main content
. Author manuscript; available in PMC: 2015 Jul 15.
Published in final edited form as: Circulation. 2014 May 9;130(3):265–272. doi: 10.1161/CIRCULATIONAHA.113.007826

Table 1.

The various time intervals in the endovascular arm of the IMS-III trial. (IQR: interquartile range)

Time Interval (Minutes) Median IQR
Stroke Onset to ED Arrival (N= 418) 50 34
ED Arrival to baseline CT (N= 413) 19 15
Baseline CT to IV bolus (N=412) 42 30
 Baseline CT to IV (patients with CTA, N=206) 39 27
  Baseline CT to CTA (N= 206) 6 7
  Baseline CTA to IV bolus (N= 207) 31 24
  Baseline CT to IV bolus (patients without CTA, N= 206) 47 28
IV tPA Bolus to groin Puncture (N=407) 85 41
 IV tPA Bolus to randomization (N= 417) 24 25
 Randomization to groin Puncture (N= 408) 62 38
Groin puncture to thrombus identification (N= 327) 15 15
Thrombus identification to Endovascular therapy initiation (N= 310) 20.5 24
Endovascular therapy initiation to reperfusion (N= 312) 85 74
IV tPA bolus to Endovascular therapy initiation (N= 314) 125.5 46